| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.927 | 0.002 | 0.943 | Vasodilator, coronary | 0.943 0.002 DBMET00619 0.801 0.004 DBMET00131 0.852 0.003 DBMET00132 0.943 0.002 DBMET00471 0.705 0.004 DBMET01234 0.821 0.004 DBMET01235 0.868 0.003 DBMET01236 | DBMET00471 | |
| 0.834 | 0.004 | 0.834 | Cardiotonic | 0.797 0.004 DBMET00619 0.76 0.005 DBMET00131 0.776 0.004 DBMET00132 0.797 0.004 DBMET00471 0.767 0.005 DBMET01234 0.72 0.005 DBMET01235 0.738 0.005 DBMET01236 | ||
| 0.817 | 0.004 | 0.858 | Spasmolytic | 0.858 0.004 DBMET00619 0.699 0.006 DBMET00131 0.614 0.012 DBMET00132 0.858 0.004 DBMET00471 0.6 0.013 DBMET01234 0.749 0.005 DBMET01235 0.669 0.008 DBMET01236 | DBMET00471 | |
| 0.806 | 0.001 | 0.806 | Calcium antagonist | 0.655 0.001 DBMET00619 0.548 0.002 DBMET00131 0.644 0.001 DBMET00132 0.655 0.001 DBMET00471 0.526 0.002 DBMET01234 0.415 0.003 DBMET01235 0.535 0.002 DBMET01236 | ||
| 0.787 | 0.003 | 0.787 | Calcium channel blocker | 0.647 0.003 DBMET00619 0.538 0.004 DBMET00131 0.584 0.004 DBMET00132 0.647 0.003 DBMET00471 0.429 0.005 DBMET01234 0.388 0.005 DBMET01235 0.432 0.005 DBMET01236 | ||
| 0.768 | 0.003 | 0.768 | P-glycoprotein inhibitor | 0.732 0.004 DBMET00619 0.745 0.004 DBMET00131 0.74 0.004 DBMET00132 0.732 0.004 DBMET00471 0.75 0.004 DBMET01234 0.705 0.004 DBMET01235 0.7 0.004 DBMET01236 | ||
| 0.622 | 0.004 | 0.647 | Anesthetic general | 0.647 0.004 DBMET00619 0.499 0.008 DBMET00131 0.411 0.015 DBMET00132 0.647 0.004 DBMET00471 0.52 0.007 DBMET01234 0.525 0.006 DBMET01235 0.442 0.012 DBMET01236 | DBMET00471 | |
| 0.59 | 0.004 | 0.59 | Calcium channel (voltage-sensitive) blocker | 0.389 0.005 DBMET00619 0.32 0.005 DBMET00131 0.338 0.005 DBMET00132 0.389 0.005 DBMET00471 0.226 0.013 DBMET01234 0.203 0.016 DBMET01235 0.215 0.014 DBMET01236 | ||
| 0.578 | 0.007 | 0.578 | Vasodilator | 0.573 0.007 DBMET00619 0.539 0.009 DBMET00131 0.532 0.01 DBMET00132 0.573 0.007 DBMET00471 0.536 0.009 DBMET01234 0.538 0.009 DBMET01235 0.532 0.01 DBMET01236 | ||
| 0.581 | 0.018 | 0.618 | Vasodilator, peripheral | 0.613 0.015 DBMET00619 0.531 0.023 DBMET00131 0.588 0.017 DBMET00132 0.613 0.015 DBMET00471 0.401 0.055 DBMET01234 0.577 0.018 DBMET01235 0.618 0.014 DBMET01236 | DBMET01236 | |
| 0.553 | 0.02 | 0.572 | Immunosuppressant | 0.546 0.022 DBMET00619 0.547 0.021 DBMET00131 0.557 0.019 DBMET00132 0.546 0.022 DBMET00471 0.572 0.017 DBMET01234 0.54 0.023 DBMET01235 0.548 0.021 DBMET01236 | DBMET01234 | |
| 0.529 | 0.004 | 0.529 | Nav1.2 sodium channel blocker | 0.387 0.008 DBMET00619 0.43 0.006 DBMET00131 0.398 0.007 DBMET00132 0.387 0.008 DBMET00471 0.392 0.007 DBMET01234 0.32 0.013 DBMET01235 0.296 0.015 DBMET01236 | ||
| 0.52 | 0.002 | 0.52 | Calcium channel L-type blocker | 0.421 0.003 DBMET00619 0.326 0.004 DBMET00131 0.354 0.003 DBMET00132 0.421 0.003 DBMET00471 0.242 0.004 DBMET01234 0.244 0.004 DBMET01235 0.274 0.004 DBMET01236 | ||
| 0.51 | 0.004 | 0.51 | Anesthetic local | 0.49 0.004 DBMET00619 0.427 0.005 DBMET00131 0.309 0.012 DBMET00132 0.49 0.004 DBMET00471 0.283 0.014 DBMET01234 0.408 0.006 DBMET01235 0.294 0.013 DBMET01236 | ||
| 0.447 | 0.004 | 0.447 | Nav1.6 sodium channel blocker | 0.321 0.005 DBMET00619 0.4 0.004 DBMET00131 0.276 0.007 DBMET00132 0.321 0.005 DBMET00471 0.372 0.004 DBMET01234 0.273 0.007 DBMET01235 0.196 0.02 DBMET01236 | ||
| 0.383 | 0.005 | 0.383 | Nav1.3 sodium channel blocker | 0.258 0.013 DBMET00619 0.382 0.005 DBMET00131 0.287 0.01 DBMET00132 0.258 0.013 DBMET00471 0.24 0.015 DBMET01234 0.257 0.013 DBMET01235 0.191 0.028 DBMET01236 | ||
| 0.384 | 0.053 | 0.428 | Antithrombotic | 0.428 0.043 DBMET00619 0.356 0.062 DBMET00131 0.33 0.072 DBMET00132 0.428 0.043 DBMET00471 0.392 0.051 DBMET01234 0.398 0.05 DBMET01235 0.372 0.057 DBMET01236 | DBMET00471 | |
| 0.381 | 0.05 | 0.574 | Aldehyde oxidase inhibitor | 0.574 0.022 DBMET00619 0.333 0.058 DBMET00131 0.181 0.116 DBMET00132 0.574 0.022 DBMET00471 0.464 0.038 DBMET01234 0.542 0.027 DBMET01235 0.325 0.06 DBMET01236 | DBMET00471 | |
| 0.324 | 0.007 | 0.327 | Nav1.1 sodium channel blocker | 0.291 0.009 DBMET00619 0.327 0.007 DBMET00131 0.293 0.009 DBMET00132 0.291 0.009 DBMET00471 0.306 0.008 DBMET01234 0.293 0.009 DBMET01235 0.253 0.012 DBMET01236 | DBMET00131 | |
| 0.286 | 0.017 | 0.286 | Alpha adrenoreceptor antagonist | 0.244 0.021 DBMET00619 0.202 0.027 DBMET00131 0.211 0.026 DBMET00132 0.244 0.021 DBMET00471 0.096 0.059 DBMET01234 0.166 0.034 DBMET01235 0.174 0.032 DBMET01236 | ||
| 0.255 | 0.004 | 0.255 | Calcium channel T-type blocker | 0.149 0.007 DBMET00619 0.115 0.012 DBMET00131 0.142 0.008 DBMET00132 0.149 0.007 DBMET00471 0.104 0.015 DBMET01234 0.062 0.035 DBMET01235 0.076 0.024 DBMET01236 | ||
| 0.23 | 0.011 | 0.23 | Calcium channel N-type blocker | 0.157 0.034 DBMET00619 0.182 0.022 DBMET00131 0.178 0.023 DBMET00132 0.157 0.034 DBMET00471 0.131 0.051 DBMET01234 0.12 0.063 DBMET01235 0.117 0.066 DBMET01236 | ||
| 0.237 | 0.019 | 0.337 | Antiadrenergic | 0.219 0.021 DBMET00619 0.176 0.029 DBMET00131 0.337 0.011 DBMET00132 0.219 0.021 DBMET00471 0.116 0.047 DBMET01234 0.166 0.032 DBMET01235 0.304 0.013 DBMET01236 | DBMET00132 | |
| 0.222 | 0.008 | 0.306 | Vanilloid 1 agonist | 0.292 0.004 DBMET00619 0.228 0.007 DBMET00131 0.209 0.01 DBMET00132 0.292 0.004 DBMET00471 0.216 0.009 DBMET01234 0.306 0.004 DBMET01235 0.262 0.005 DBMET01236 | DBMET01235 | |
| 0.23 | 0.019 | 0.334 | Adrenaline antagonist | 0.213 0.021 DBMET00619 0.171 0.029 DBMET00131 0.334 0.011 DBMET00132 0.213 0.021 DBMET00471 0.112 0.047 DBMET01234 0.16 0.032 DBMET01235 0.301 0.013 DBMET01236 | DBMET00132 | |
| 0.218 | 0.007 | 0.218 | Sphingomyelinase inhibitor | 0.191 0.011 DBMET00619 0.168 0.018 DBMET00131 0.127 0.037 DBMET00132 0.191 0.011 DBMET00471 0.114 0.046 DBMET01234 0.14 0.029 DBMET01235 0.103 0.056 DBMET01236 | ||
| 0.214 | 0.007 | 0.246 | Prolactin inhibitor | 0.246 0.004 DBMET00619 0.093 0.063 DBMET00131 0.093 0.063 DBMET00132 0.246 0.004 DBMET00471 0.101 0.054 DBMET01234 0.118 0.04 DBMET01235 0.117 0.04 DBMET01236 | DBMET00471 | |
| 0.214 | 0.008 | 0.214 | Multidrug resistance-associated protein 1 inhibitor | 0.207 0.009 DBMET00619 0.165 0.019 DBMET00131 0.184 0.014 DBMET00132 0.207 0.009 DBMET00471 0.186 0.014 DBMET01234 0.159 0.021 DBMET01235 0.177 0.016 DBMET01236 | ||
| 0.229 | 0.031 | 0.234 | Acetylcholine M1 receptor antagonist | 0.234 0.03 DBMET00619 0.147 0.077 DBMET00131 0.16 0.066 DBMET00132 0.234 0.03 DBMET00471 0.147 0.078 DBMET01234 0.15 0.074 DBMET01235 0.163 0.063 DBMET01236 | DBMET00471 | |
| 0.214 | 0.027 | 0.214 | 5 Hydroxytryptamine 2 antagonist | 0.124 0.056 DBMET00619 0.127 0.055 DBMET00131 0.1 0.072 DBMET00132 0.124 0.056 DBMET00471 | ||
| 0.252 | 0.065 | 0.252 | Potassium channel blocker | |||
| 0.261 | 0.085 | 0.261 | Ca(v)3.3 blocker | 0.212 0.166 DBMET00619 0.257 0.09 DBMET00131 0.261 0.085 DBMET00132 0.212 0.166 DBMET00471 0.227 0.139 DBMET01234 0.205 0.182 DBMET01235 0.211 0.169 DBMET01236 | ||
| 0.248 | 0.076 | 0.264 | Tumour necrosis factor alpha release inhibitor | 0.264 0.069 DBMET00619 0.226 0.088 DBMET00131 0.264 0.069 DBMET00471 0.19 0.118 DBMET01234 0.243 0.078 DBMET01235 0.174 0.131 DBMET01236 | DBMET00471 | |
| 0.171 | 0.004 | 0.192 | Potassium channel Kv1.3 blocker | 0.158 0.004 DBMET00619 0.161 0.004 DBMET00131 0.192 0.004 DBMET00132 0.158 0.004 DBMET00471 0.136 0.005 DBMET01234 0.149 0.004 DBMET01235 0.179 0.004 DBMET01236 | DBMET00132 | |
| 0.255 | 0.092 | 0.282 | Insulysin inhibitor | 0.282 0.07 DBMET00619 0.234 0.112 DBMET00131 0.251 0.095 DBMET00132 0.282 0.07 DBMET00471 0.251 0.095 DBMET01234 0.262 0.086 DBMET01235 0.278 0.073 DBMET01236 | DBMET00471 | |
| 0.163 | 0.007 | 0.337 | Glutamate release inhibitor | 0.133 0.015 DBMET00619 0.321 0.003 DBMET00131 0.163 0.007 DBMET00132 0.133 0.015 DBMET00471 0.337 0.003 DBMET01234 0.262 0.004 DBMET01235 0.133 0.015 DBMET01236 | DBMET01234 | |
| 0.153 | 0.004 | 0.172 | Estrogen-related receptor beta agonist | 0.172 0.003 DBMET00619 0.128 0.007 DBMET00131 0.149 0.004 DBMET00132 0.172 0.003 DBMET00471 0.114 0.013 DBMET01234 0.142 0.005 DBMET01235 0.167 0.003 DBMET01236 | DBMET00471 | |
| 0.157 | 0.009 | 0.198 | Histamine H2 receptor antagonist | 0.116 0.023 DBMET00619 0.198 0.005 DBMET00131 0.158 0.008 DBMET00132 0.116 0.023 DBMET00471 0.124 0.019 DBMET01234 0.137 0.014 DBMET01235 0.117 0.023 DBMET01236 | DBMET00131 | |
| 0.167 | 0.024 | 0.167 | 5 Hydroxytryptamine 2A antagonist | 0.091 0.052 DBMET00619 0.086 0.055 DBMET00131 0.071 0.066 DBMET00132 0.091 0.052 DBMET00471 | ||
| 0.237 | 0.096 | 0.536 | 5 Hydroxytryptamine release stimulant | 0.198 0.123 DBMET00619 0.423 0.041 DBMET00131 0.536 0.022 DBMET00132 0.198 0.123 DBMET00471 0.415 0.043 DBMET01234 0.35 0.056 DBMET01235 0.477 0.031 DBMET01236 | DBMET00132 | |
| 0.148 | 0.011 | 0.197 | Vanilloid agonist | 0.197 0.007 DBMET00619 0.136 0.013 DBMET00131 0.137 0.013 DBMET00132 0.197 0.007 DBMET00471 0.14 0.012 DBMET01234 0.181 0.008 DBMET01235 0.18 0.008 DBMET01236 | DBMET00471 | |
| 0.156 | 0.018 | 0.156 | Electron transport complex I inhibitor | 0.15 0.02 DBMET00619 0.141 0.026 DBMET00131 0.15 0.021 DBMET00132 0.15 0.02 DBMET00471 0.131 0.035 DBMET01234 0.137 0.029 DBMET01235 0.145 0.024 DBMET01236 | ||
| 0.157 | 0.023 | 0.187 | Nav1.5 sodium channel blocker | 0.121 0.053 DBMET00619 0.162 0.021 DBMET00131 0.187 0.015 DBMET00132 0.121 0.053 DBMET00471 0.157 0.024 DBMET01234 0.125 0.049 DBMET01235 0.138 0.035 DBMET01236 | DBMET00132 | |
| 0.261 | 0.134 | 0.349 | Calcium channel activator | 0.214 0.192 DBMET00619 0.349 0.05 DBMET00131 0.347 0.052 DBMET00132 0.214 0.192 DBMET00471 0.301 0.091 DBMET01234 0.31 0.082 DBMET01235 0.307 0.084 DBMET01236 | DBMET00131 | |
| 0.163 | 0.038 | 0.208 | Cholesterol synthesis inhibitor | 0.208 0.025 DBMET00619 0.208 0.025 DBMET00471 0.098 0.09 DBMET01236 | DBMET00471 | |
| 0.249 | 0.126 | 0.3 | Cholesterol antagonist | 0.3 0.091 DBMET00619 0.198 0.166 DBMET00131 0.3 0.091 DBMET00471 0.199 0.165 DBMET01234 0.253 0.123 DBMET01235 0.217 0.15 DBMET01236 | DBMET00471 | |
| 0.2 | 0.078 | 0.33 | Amyloid beta aggregation inhibitor | 0.33 0.039 DBMET00619 0.139 0.117 DBMET00132 0.33 0.039 DBMET00471 0.135 0.12 DBMET01234 0.237 0.062 DBMET01235 0.256 0.056 DBMET01236 | DBMET00471 | |
| 0.21 | 0.089 | 0.21 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.158 | 0.044 | 0.174 | Farnesoid X receptor antagonist | 0.174 0.032 DBMET00619 0.156 0.045 DBMET00131 0.156 0.045 DBMET00132 0.174 0.032 DBMET00471 0.164 0.039 DBMET01234 0.173 0.033 DBMET01235 0.173 0.033 DBMET01236 | DBMET00471 | |
| 0.154 | 0.042 | 0.154 | Acetylcholine muscarinic antagonist | 0.151 0.043 DBMET00619 0.107 0.083 DBMET00132 0.151 0.043 DBMET00471 0.104 0.085 DBMET01236 | ||
| 0.148 | 0.042 | 0.148 | 5 Hydroxytryptamine 2B antagonist | 0.108 0.074 DBMET00619 0.099 0.085 DBMET00131 0.108 0.074 DBMET00471 | ||
| 0.177 | 0.07 | 0.192 | MAP kinase kinase 5 inhibitor | 0.164 0.102 DBMET00619 0.191 0.044 DBMET00131 0.171 0.082 DBMET00132 0.164 0.102 DBMET00471 0.192 0.043 DBMET01234 0.177 0.068 DBMET01235 0.159 0.12 DBMET01236 | DBMET01234 | |
| 0.108 | 0.005 | 0.108 | Calcium channel P-type blocker | 0.082 0.013 DBMET00619 0.061 0.056 DBMET00131 0.069 0.03 DBMET00132 0.082 0.013 DBMET00471 0.065 0.04 DBMET01234 | ||
| 0.147 | 0.054 | 0.147 | Cholinergic antagonist | 0.133 0.063 DBMET00619 0.133 0.063 DBMET00471 | ||
| 0.144 | 0.054 | 0.144 | Acetylcholine antagonist | 0.129 0.062 DBMET00619 0.129 0.062 DBMET00471 | ||
| 0.188 | 0.098 | 0.188 | HERG channel blocker | |||
| 0.093 | 0.006 | 0.107 | Vanilloid 2 antagonist | 0.107 0.005 DBMET00619 0.068 0.016 DBMET00131 0.086 0.008 DBMET00132 0.107 0.005 DBMET00471 0.07 0.014 DBMET01234 0.081 0.009 DBMET01235 0.1 0.005 DBMET01236 | DBMET00471 | |
| 0.122 | 0.036 | 0.122 | Alpha 1 adrenoreceptor antagonist | 0.085 0.05 DBMET00619 0.086 0.049 DBMET00131 0.092 0.047 DBMET00132 0.085 0.05 DBMET00471 | ||
| 0.122 | 0.036 | 0.184 | Protein kinase C delta inhibitor | 0.114 0.041 DBMET00619 0.149 0.021 DBMET00131 0.116 0.039 DBMET00132 0.114 0.041 DBMET00471 0.184 0.011 DBMET01234 0.14 0.026 DBMET01235 0.109 0.045 DBMET01236 | DBMET01234 | |
| 0.18 | 0.097 | 0.18 | Platelet aggregation inhibitor | 0.147 0.132 DBMET00619 0.169 0.108 DBMET00131 0.152 0.126 DBMET00132 0.147 0.132 DBMET00471 0.171 0.106 DBMET01234 | ||
| 0.159 | 0.082 | 0.204 | Neurotensin receptor agonist | 0.16 0.079 DBMET00619 0.173 0.058 DBMET00131 0.193 0.039 DBMET00132 0.16 0.079 DBMET00471 0.204 0.033 DBMET01234 0.174 0.056 DBMET01235 0.194 0.038 DBMET01236 | DBMET01234 | |
| 0.115 | 0.039 | 0.115 | Alpha 2 adrenoreceptor antagonist | 0.113 0.039 DBMET00619 0.089 0.056 DBMET00131 0.113 0.039 DBMET00471 0.088 0.057 DBMET01235 | ||
| 0.125 | 0.05 | 0.138 | Falcipain 3 inhibitor | 0.122 0.052 DBMET00619 0.11 0.061 DBMET00131 0.138 0.043 DBMET00132 0.122 0.052 DBMET00471 0.107 0.064 DBMET01235 0.135 0.044 DBMET01236 | DBMET00132 | |
| 0.141 | 0.068 | 0.152 | Neurotrophic factor | 0.152 0.057 DBMET00619 0.152 0.057 DBMET00471 0.112 0.109 DBMET01235 0.124 0.089 DBMET01236 | DBMET00471 | |
| 0.135 | 0.064 | 0.186 | Sphingosine 1-phosphate receptor 2 antagonist | 0.138 0.059 DBMET00619 0.136 0.062 DBMET00131 0.182 0.014 DBMET00132 0.138 0.059 DBMET00471 0.132 0.069 DBMET01234 0.14 0.056 DBMET01235 0.186 0.012 DBMET01236 | DBMET01236 | |
| 0.074 | 0.006 | 0.074 | Benzodiazepine antagonist | 0.052 0.023 DBMET00619 0.051 0.025 DBMET00131 0.052 0.023 DBMET00471 | ||
| 0.103 | 0.034 | 0.103 | Alpha 1b adrenoreceptor antagonist | 0.077 0.048 DBMET00619 0.093 0.038 DBMET00131 0.084 0.043 DBMET00132 0.077 0.048 DBMET00471 0.07 0.053 DBMET01235 0.061 0.06 DBMET01236 | ||
| 0.278 | 0.219 | 0.376 | Caspase 9 stimulant | 0.33 0.163 DBMET00619 0.318 0.175 DBMET00131 0.253 0.25 DBMET00132 0.33 0.163 DBMET00471 0.358 0.139 DBMET01234 0.376 0.126 DBMET01235 0.305 0.188 DBMET01236 | DBMET01235 | |
| 0.097 | 0.038 | 0.105 | Alpha 2a adrenoreceptor antagonist | 0.105 0.034 DBMET00619 0.095 0.039 DBMET00131 0.105 0.034 DBMET00471 0.104 0.035 DBMET01235 0.068 0.06 DBMET01236 | DBMET00471 | |
| 0.116 | 0.064 | 0.148 | TRPA1 agonist | 0.117 0.062 DBMET00619 0.126 0.052 DBMET00131 0.14 0.038 DBMET00132 0.117 0.062 DBMET00471 0.148 0.032 DBMET01234 0.127 0.051 DBMET01235 0.142 0.037 DBMET01236 | DBMET01234 | |
| 0.124 | 0.075 | 0.124 | Acetylcholinesterase inhibitor | 0.12 0.078 DBMET00619 0.12 0.078 DBMET00471 | ||
| 0.106 | 0.057 | 0.216 | Bronchodilator | 0.114 0.049 DBMET00619 0.114 0.049 DBMET00131 0.216 0.016 DBMET00132 0.114 0.049 DBMET00471 0.089 0.076 DBMET01234 0.124 0.042 DBMET01235 0.215 0.016 DBMET01236 | DBMET00132 | |
| 0.158 | 0.109 | 0.158 | Psychostimulant | 0.152 0.115 DBMET00619 0.137 0.129 DBMET00131 0.152 0.115 DBMET00471 | ||
| 0.208 | 0.161 | 0.36 | Transcription factor NF kappa B inhibitor | 0.295 0.097 DBMET00619 0.255 0.124 DBMET00131 0.26 0.12 DBMET00132 0.295 0.097 DBMET00471 0.26 0.12 DBMET01234 0.354 0.076 DBMET01235 0.36 0.074 DBMET01236 | DBMET01236 | |
| 0.079 | 0.034 | 0.122 | Protein kinase C alpha inhibitor | 0.073 0.041 DBMET00619 0.097 0.024 DBMET00131 0.064 0.054 DBMET00132 0.073 0.041 DBMET00471 0.122 0.015 DBMET01234 0.087 0.029 DBMET01235 | DBMET01234 | |
| 0.048 | 0.008 | 0.048 | Benzodiazepine receptor peripheral-type antagonist | 0.04 0.014 DBMET00619 0.034 0.024 DBMET00131 0.04 0.014 DBMET00471 | ||
| 0.064 | 0.026 | 0.064 | Sigma receptor antagonist | 0.05 0.034 DBMET00619 0.05 0.034 DBMET00471 | ||
| 0.196 | 0.159 | 0.288 | 5 Hydroxytryptamine uptake stimulant | 0.215 0.124 DBMET00619 0.219 0.118 DBMET00131 0.23 0.104 DBMET00132 0.215 0.124 DBMET00471 0.288 0.051 DBMET01234 0.241 0.09 DBMET01235 0.253 0.078 DBMET01236 | DBMET01234 | |
| 0.138 | 0.1 | 0.266 | Melanin inhibitor | 0.175 0.055 DBMET00619 0.147 0.086 DBMET00131 0.183 0.05 DBMET00132 0.175 0.055 DBMET00471 0.192 0.044 DBMET01234 0.187 0.047 DBMET01235 0.266 0.026 DBMET01236 | DBMET01236 | |
| 0.041 | 0.005 | 0.042 | Leukotriene B4 receptor 2 antagonist | 0.042 0.005 DBMET00619 0.042 0.005 DBMET00471 0.021 0.017 DBMET01236 | DBMET00471 | |
| 0.089 | 0.054 | 0.089 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.045 | 0.012 | 0.095 | Melatonin 1 agonist | 0.036 0.019 DBMET00619 0.05 0.01 DBMET00131 0.095 0.004 DBMET00132 0.036 0.019 DBMET00471 0.034 0.021 DBMET01234 0.039 0.016 DBMET01235 0.074 0.005 DBMET01236 | DBMET00132 | |
| 0.07 | 0.037 | 0.07 | Dopamine D3 antagonist | 0.057 0.048 DBMET00619 0.054 0.051 DBMET00132 0.057 0.048 DBMET00471 | ||
| 0.061 | 0.03 | 0.061 | Acetyl-CoA transferase 2 inhibitor | 0.06 0.032 DBMET00619 0.06 0.032 DBMET00471 | ||
| 0.041 | 0.012 | 0.041 | Sigma 1 receptor antagonist | 0.028 0.018 DBMET00619 0.028 0.018 DBMET00471 | ||
| 0.114 | 0.085 | 0.179 | Tubulin antagonist | 0.148 0.058 DBMET00619 0.139 0.064 DBMET00131 0.12 0.08 DBMET00132 0.148 0.058 DBMET00471 0.143 0.061 DBMET01234 0.179 0.045 DBMET01235 0.157 0.055 DBMET01236 | DBMET01235 | |
| 0.13 | 0.102 | 0.185 | Adenylate cyclase stimulant | 0.156 0.053 DBMET00619 0.159 0.048 DBMET00131 0.157 0.051 DBMET00132 0.156 0.053 DBMET00471 0.156 0.053 DBMET01234 0.185 0.022 DBMET01235 0.183 0.023 DBMET01236 | DBMET01235 | |
| 0.16 | 0.134 | 0.196 | Platelet antagonist | 0.167 0.128 DBMET00619 0.179 0.118 DBMET00132 0.167 0.128 DBMET00471 0.196 0.104 DBMET01234 0.151 0.143 DBMET01235 0.184 0.114 DBMET01236 | DBMET01234 | |
| 0.038 | 0.013 | 0.041 | Leukotriene B4 receptor 1 antagonist | 0.041 0.011 DBMET00619 0.041 0.011 DBMET00471 | DBMET00471 | |
| 0.04 | 0.015 | 0.122 | Melatonin agonist | 0.031 0.025 DBMET00619 0.042 0.013 DBMET00131 0.122 0.004 DBMET00132 0.031 0.025 DBMET00471 0.033 0.023 DBMET01235 0.082 0.005 DBMET01236 | DBMET00132 | |
| 0.128 | 0.105 | 0.128 | Sigma receptor agonist | |||
| 0.059 | 0.038 | 0.076 | Protein kinase C theta inhibitor | 0.067 0.027 DBMET00131 0.063 0.033 DBMET00132 0.076 0.017 DBMET01234 0.056 0.042 DBMET01235 0.052 0.05 DBMET01236 | DBMET01234 | |
| 0.032 | 0.014 | 0.032 | Urotensin II agonist | 0.028 0.017 DBMET00619 0.028 0.017 DBMET00471 | ||
| 0.101 | 0.085 | 0.122 | Acetylcholine release stimulant | 0.121 0.047 DBMET00131 0.122 0.046 DBMET00132 | DBMET00132 | |
| 0.05 | 0.034 | 0.065 | Squalene epoxidase inhibitor | 0.054 0.027 DBMET00619 0.06 0.021 DBMET00131 0.054 0.027 DBMET00471 0.052 0.03 DBMET01234 0.065 0.017 DBMET01235 | DBMET01235 | |
| 0.034 | 0.019 | 0.034 | Vanilloid 4 antagonist | 0.034 0.02 DBMET00619 0.034 0.02 DBMET00471 | ||
| 0.075 | 0.06 | 0.075 | Acetylcholine nicotinic antagonist | |||
| 0.141 | 0.127 | 0.205 | Phospholipase C inhibitor | 0.167 0.077 DBMET00619 0.137 0.135 DBMET00131 0.152 0.102 DBMET00132 0.167 0.077 DBMET00471 0.205 0.041 DBMET01234 0.163 0.083 DBMET01235 0.18 0.061 DBMET01236 | DBMET01234 | |
| 0.037 | 0.025 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.177 | 0.167 | 0.235 | Neuropeptide Y2 antagonist | 0.186 0.146 DBMET00131 0.199 0.12 DBMET00132 0.235 0.071 DBMET01234 | DBMET01234 | |
| 0.02 | 0.01 | 0.027 | Estrogen-related receptor gamma agonist | 0.027 0.005 DBMET00619 0.027 0.005 DBMET00471 0.022 0.008 DBMET01235 0.022 0.008 DBMET01236 | DBMET00471 | |
| 0.05 | 0.041 | 0.05 | 5 Hydroxytryptamine 1B agonist | |||
| 0.085 | 0.076 | 0.085 | Butyrylcholinesterase inhibitor | |||
| 0.027 | 0.018 | 0.027 | Sigma 2 receptor antagonist | |||
| 0.051 | 0.043 | 0.06 | Leukotriene B4 antagonist | 0.06 0.028 DBMET00619 0.06 0.028 DBMET00471 | DBMET00471 | |
| 0.056 | 0.049 | 0.056 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.092 | 0.086 | 0.092 | 5 Hydroxytryptamine antagonist | |||
| 0.074 | 0.071 | 0.111 | Ca(v)2.2 blocker | 0.111 0.042 DBMET00131 0.087 0.058 DBMET00132 0.09 0.056 DBMET01234 | DBMET00131 | |
| 0.088 | 0.095 | 0.139 | Chelator | 0.139 0.04 DBMET00619 0.139 0.04 DBMET00471 0.119 0.055 DBMET01235 0.127 0.047 DBMET01236 | DBMET00471 | |
| 0.144 | 0.153 | 0.318 | Free radical scavenger | 0.283 0.056 DBMET00619 0.17 0.124 DBMET00132 0.283 0.056 DBMET00471 0.156 0.138 DBMET01234 0.281 0.057 DBMET01235 0.318 0.047 DBMET01236 | DBMET01236 | |
| 0.176 | 0.185 | 0.26 | Tyrosine 3 hydroxylase inhibitor | 0.217 0.108 DBMET00619 0.198 0.14 DBMET00131 0.214 0.112 DBMET00132 0.217 0.108 DBMET00471 0.248 0.07 DBMET01234 0.241 0.077 DBMET01235 0.26 0.059 DBMET01236 | DBMET01236 | |
| 0.073 | 0.085 | 0.085 | Ca(v)3.1 blocker | 0.085 0.046 DBMET00132 0.078 0.066 DBMET01236 | DBMET00132 | |
| 0.151 | 0.165 | 0.285 | Antioxidant | 0.273 0.073 DBMET00619 0.16 0.153 DBMET00132 0.273 0.073 DBMET00471 0.157 0.156 DBMET01234 0.265 0.076 DBMET01235 0.285 0.068 DBMET01236 | DBMET01236 | |
| 0.041 | 0.056 | 0.099 | Beta tubulin antagonist | 0.075 0.032 DBMET00619 0.064 0.038 DBMET00131 0.049 0.047 DBMET00132 0.075 0.032 DBMET00471 0.099 0.022 DBMET01235 0.085 0.027 DBMET01236 | DBMET01235 | |
| 0.055 | 0.071 | 0.083 | Beta 3 adrenoreceptor antagonist | 0.069 0.035 DBMET00619 0.064 0.044 DBMET00132 0.069 0.035 DBMET00471 0.059 0.058 DBMET01235 0.083 0.021 DBMET01236 | DBMET01236 | |
| 0.032 | 0.049 | 0.046 | Neurokinin 2 agonist | 0.046 0.023 DBMET01234 | DBMET01234 | |
| 0.188 | 0.205 | 0.275 | Sodium/bile acid cotransporter inhibitor | 0.241 0.138 DBMET00619 0.229 0.151 DBMET00131 0.223 0.158 DBMET00132 0.241 0.138 DBMET00471 0.275 0.103 DBMET01235 0.269 0.109 DBMET01236 | DBMET01235 | |
| 0.035 | 0.053 | 0.04 | Cathepsin F inhibitor | 0.04 0.035 DBMET00132 | DBMET00132 | |
| 0.065 | 0.085 | 0.173 | Ornithine decarboxylase inhibitor | 0.081 0.066 DBMET00619 0.135 0.017 DBMET00131 0.123 0.024 DBMET00132 0.081 0.066 DBMET00471 0.173 0.007 DBMET01234 0.149 0.011 DBMET01235 0.135 0.017 DBMET01236 | DBMET01234 | |
| 0.05 | 0.075 | 0.105 | Beta adrenoreceptor antagonist | 0.07 0.039 DBMET00619 0.078 0.029 DBMET00132 0.07 0.039 DBMET00471 0.065 0.047 DBMET01235 0.105 0.015 DBMET01236 | DBMET01236 | |
| 0.071 | 0.098 | 0.119 | Breast cancer-resistant protein inhibitor | 0.117 0.041 DBMET00132 0.119 0.04 DBMET01236 | DBMET01236 | |
| 0.09 | 0.119 | 0.11 | Bone formation stimulant | 0.11 0.096 DBMET00619 0.11 0.096 DBMET00471 | DBMET00471 | |
| 0.03 | 0.061 | 0.041 | Neurotensin receptor antagonist | 0.041 0.036 DBMET01234 | DBMET01234 | |
| 0.037 | 0.072 | 0.083 | Beta 1 adrenoreceptor antagonist | 0.054 0.042 DBMET00619 0.068 0.028 DBMET00132 0.054 0.042 DBMET00471 0.083 0.016 DBMET01236 | DBMET01236 | |
| 0.02 | 0.056 | 0.06 | Melatonin 2 agonist | 0.06 0.008 DBMET00132 0.049 0.011 DBMET01236 | DBMET00132 | |
| 0.024 | 0.063 | 0.036 | Melatonin receptor 1A agonist | 0.031 0.03 DBMET00131 0.036 0.018 DBMET00132 | DBMET00132 | |
| 0.036 | 0.076 | 0.065 | 5 Hydroxytryptamine uptake inhibitor | 0.065 0.042 DBMET00131 | DBMET00131 | |
| 0.015 | 0.057 | 0.028 | Dipeptidyl peptidase I inhibitor | 0.028 0.024 DBMET01234 | DBMET01234 | |
| 0.06 | 0.104 | 0.078 | Estrogen receptor alpha antagonist | 0.078 0.052 DBMET00619 0.078 0.052 DBMET00471 0.071 0.066 DBMET01236 | DBMET00471 | |
| 0.146 | 0.192 | 0.176 | ErbB-1 antagonist | 0.176 0.122 DBMET00131 0.165 0.144 DBMET00132 0.169 0.135 DBMET01235 0.159 0.158 DBMET01236 | DBMET00131 | |
| 0.007 | 0.055 | 0.013 | Melatonin receptor 1A antagonist | 0.013 0.012 DBMET00132 | DBMET00132 | |
| 0.12 | 0.169 | 0.152 | Anticonvulsant | 0.152 0.127 DBMET01234 | DBMET01234 | |
| 0.009 | 0.058 | 0.023 | Melatonin 1 antagonist | 0.023 0.009 DBMET00132 | DBMET00132 | |
| 0.051 | 0.103 | 0.074 | Beta 2 adrenoreceptor agonist | 0.061 0.047 DBMET00619 0.064 0.034 DBMET00132 0.061 0.047 DBMET00471 0.074 0.014 DBMET01236 | DBMET01236 | |
| 0.087 | 0.139 | 0.153 | Cathepsin H inhibitor | 0.128 0.066 DBMET00131 0.133 0.06 DBMET00132 0.153 0.044 DBMET01234 | DBMET01234 | |
| 0.126 | 0.18 | 0.196 | Antiamyloidogenic | 0.196 0.103 DBMET00619 0.196 0.103 DBMET00471 0.179 0.115 DBMET01235 0.157 0.138 DBMET01236 | DBMET00471 | |
| 0.111 | 0.166 | 0.157 | Tumour necrosis factor antagonist | 0.141 0.112 DBMET00131 0.157 0.092 DBMET01234 | DBMET01234 | |
| 0.011 | 0.067 | 0.037 | Melatonin antagonist | 0.037 0.011 DBMET00132 0.026 0.023 DBMET01236 | DBMET00132 | |
| 0.044 | 0.103 | 0.054 | Immunoglobulin Fc receptor antagonist | 0.054 0.041 DBMET00132 | DBMET00132 | |
| 0.082 | 0.143 | 0.179 | Toll-Like receptor 2 antagonist | 0.124 0.074 DBMET00619 0.105 0.097 DBMET00131 0.124 0.074 DBMET00132 0.124 0.074 DBMET00471 0.173 0.038 DBMET01234 0.158 0.047 DBMET01235 0.179 0.034 DBMET01236 | DBMET01236 | |
| 0.104 | 0.168 | 0.148 | Nitric oxide antagonist | 0.142 0.102 DBMET00619 0.142 0.102 DBMET00471 0.143 0.101 DBMET01235 0.148 0.096 DBMET01236 | DBMET01236 | |
| 0.188 | 0.252 | 0.287 | Analgesic | 0.287 0.151 DBMET00131 0.241 0.19 DBMET01235 | DBMET00131 | |
| 0.121 | 0.186 | 0.221 | Immunostimulant | 0.155 0.151 DBMET00619 0.155 0.151 DBMET00471 0.221 0.108 DBMET01234 0.17 0.139 DBMET01235 0.192 0.125 DBMET01236 | DBMET01234 | |
| 0.138 | 0.209 | 0.493 | Superoxide dismutase inhibitor | 0.184 0.137 DBMET00619 0.235 0.085 DBMET00131 0.29 0.054 DBMET00132 0.184 0.137 DBMET00471 0.493 0.013 DBMET01234 0.307 0.048 DBMET01235 0.391 0.028 DBMET01236 | DBMET01234 | |
| 0.048 | 0.121 | 0.081 | GABA aminotransferase inhibitor | 0.081 0.045 DBMET01234 | DBMET01234 | |
| 0.11 | 0.189 | 0.177 | Insulin sensitizer | 0.156 0.124 DBMET00132 0.177 0.099 DBMET01236 | DBMET01236 | |
| 0.075 | 0.156 | 0.139 | Cyclooxygenase 3 inhibitor | 0.124 0.073 DBMET00132 0.139 0.058 DBMET01234 0.134 0.062 DBMET01236 | DBMET01234 | |
| 0.023 | 0.111 | 0.054 | Alpha tubulin antagonist | 0.054 0.036 DBMET01236 | DBMET01236 | |
| 0.066 | 0.154 | 0.106 | Carbonic anhydrase XV inhibitor | 0.102 0.064 DBMET01234 0.106 0.059 DBMET01236 | DBMET01236 | |
| 0.072 | 0.168 | 0.108 | Sodium channel blocker | 0.108 0.1 DBMET00131 | DBMET00131 | |
| 0.044 | 0.141 | 0.088 | Somatostatin 1 agonist | 0.088 0.043 DBMET01234 | DBMET01234 | |
| 0.023 | 0.12 | 0.056 | Cathepsin L inhibitor | 0.056 0.043 DBMET00132 | DBMET00132 | |
| 0.024 | 0.128 | 0.067 | Beta 2 adrenoreceptor antagonist | 0.049 0.037 DBMET00132 0.067 0.018 DBMET01236 | DBMET01236 | |
| 0.096 | 0.204 | 0.192 | Antimitotic | 0.192 0.089 DBMET01234 0.159 0.113 DBMET01235 | DBMET01234 | |
| 0.043 | 0.151 | 0.058 | Heme oxygenase stimulant | 0.058 0.054 DBMET01235 | DBMET01235 | |
| 0.068 | 0.178 | 0.147 | Lipid peroxidase inhibitor | 0.147 0.07 DBMET00619 0.147 0.07 DBMET00471 0.112 0.102 DBMET01235 0.132 0.082 DBMET01236 | DBMET00471 | |
| 0.03 | 0.147 | 0.055 | Bombesin 1 receptor agonist | 0.055 0.047 DBMET00131 | DBMET00131 | |
| 0.095 | 0.215 | 0.13 | Interferon gamma antagonist | 0.13 0.112 DBMET01235 0.125 0.123 DBMET01236 | DBMET01235 | |
| 0.069 | 0.191 | 0.106 | Estrogen antagonist | 0.106 0.083 DBMET00619 0.106 0.083 DBMET00471 0.104 0.088 DBMET01235 0.102 0.093 DBMET01236 | DBMET00471 | |
| 0.075 | 0.2 | 0.17 | Protein kinase stimulant | 0.122 0.091 DBMET00131 0.17 0.055 DBMET01234 0.162 0.06 DBMET01235 | DBMET01234 | |
| 0.149 | 0.275 | 0.209 | Apoptosis antagonist | 0.209 0.168 DBMET00619 0.209 0.168 DBMET00471 0.203 0.175 DBMET01236 | DBMET00471 | |
| 0.011 | 0.138 | 0.03 | Catechol O-methyltransferase inhibitor | 0.03 0.027 DBMET00619 0.03 0.027 DBMET00471 | DBMET00471 | |
| 0.083 | 0.214 | 0.126 | Thiol protease inhibitor | 0.121 0.114 DBMET00132 0.126 0.105 DBMET01234 | DBMET01234 | |
| 0.129 | 0.266 | 0.267 | Peptidyltransferase inhibitor | 0.17 0.146 DBMET00619 0.243 0.056 DBMET00131 0.227 0.069 DBMET00132 0.17 0.146 DBMET00471 0.253 0.049 DBMET01234 0.267 0.04 DBMET01235 0.255 0.047 DBMET01236 | DBMET01235 | |
| 0.009 | 0.147 | 0.048 | Kinesin antagonist | 0.048 0.017 DBMET01234 | DBMET01234 | |
| 0.009 | 0.147 | 0.048 | Kinesin-like protein 1 inhibitor | 0.048 0.017 DBMET01234 | DBMET01234 | |
| 0.058 | 0.198 | 0.111 | Nav1.4 sodium channel blocker | 0.111 0.061 DBMET01234 | DBMET01234 | |
| 0.044 | 0.19 | 0.111 | Expectorant | 0.111 0.058 DBMET01234 0.103 0.065 DBMET01235 0.101 0.068 DBMET01236 | DBMET01234 | |
| 0.048 | 0.198 | 0.081 | Factor XII inhibitor | 0.081 0.065 DBMET01234 | DBMET01234 | |
| 0.051 | 0.203 | 0.122 | DNA polymerase I inhibitor | 0.122 0.067 DBMET01236 | DBMET01236 | |
| 0.169 | 0.323 | 0.301 | Apoptosis agonist | 0.263 0.201 DBMET00619 0.263 0.201 DBMET00471 0.301 0.172 DBMET01235 | DBMET01235 | |
| 0.081 | 0.238 | 0.143 | Hepatoprotectant | 0.143 0.117 DBMET01235 | DBMET01235 | |
| 0.095 | 0.256 | 0.18 | Succinate dehydrogenase inhibitor | 0.143 0.127 DBMET00131 0.18 0.068 DBMET01234 0.167 0.085 DBMET01235 0.155 0.103 DBMET01236 | DBMET01234 | |
| 0.11 | 0.277 | 0.133 | Heat shock protein 70 antagonist | 0.133 0.107 DBMET01234 | DBMET01234 | |
| 0.093 | 0.26 | 0.173 | Neurotrophic factor enhancer | 0.173 0.106 DBMET01235 | DBMET01235 | |
| 0.051 | 0.222 | 0.081 | Granulocyte macrophage colony stimulating factor agonist | 0.081 0.073 DBMET01234 | DBMET01234 | |
| 0.024 | 0.195 | 0.07 | Adrenaline uptake inhibitor | 0.07 0.034 DBMET00131 0.054 0.052 DBMET01235 | DBMET00131 | |
| 0.052 | 0.227 | 0.109 | Sodium channel (voltage-gated) blocker | 0.109 0.098 DBMET00131 | DBMET00131 | |
| 0.049 | 0.23 | 0.106 | Mucolytic | 0.106 0.069 DBMET01234 0.098 0.08 DBMET01236 | DBMET01234 | |
| 0.11 | 0.292 | 0.212 | Calpain 2 inhibitor | 0.212 0.178 DBMET00132 | DBMET00132 | |
| 0.024 | 0.209 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.029 DBMET01236 | DBMET01236 | |
| 0.033 | 0.226 | 0.078 | Inducible nitric-oxide synthase inhibitor | 0.078 0.066 DBMET00131 0.076 0.069 DBMET00132 0.078 0.066 DBMET01234 | DBMET01234 | |
| 0.043 | 0.236 | 0.094 | GABA B receptor agonist | 0.094 0.022 DBMET01234 | DBMET01234 | |
| 0.074 | 0.277 | 0.225 | Growth hormone agonist | 0.225 0.05 DBMET01234 | DBMET01234 | |
| 0.082 | 0.298 | 0.182 | Calpain inhibitor | 0.182 0.132 DBMET00132 | DBMET00132 | |
| 0.032 | 0.25 | 0.097 | Aminopeptidase B inhibitor | 0.097 0.067 DBMET01234 | DBMET01234 | |
| 0.101 | 0.322 | 0.188 | Transcription factor STAT3 inhibitor | 0.188 0.152 DBMET01234 | DBMET01234 | |
| 0.09 | 0.315 | 0.21 | Lipoxygenase inhibitor | 0.21 0.13 DBMET01235 0.204 0.136 DBMET01236 | DBMET01235 | |
| 0.129 | 0.362 | 0.303 | Interleukin 2 agonist | 0.303 0.071 DBMET01234 0.206 0.178 DBMET01235 0.221 0.155 DBMET01236 | DBMET01234 | |
| 0.116 | 0.351 | 0.203 | Nitric-oxide synthase stimulant | 0.184 0.119 DBMET00132 0.203 0.084 DBMET01236 | DBMET01236 | |
| 0.123 | 0.359 | 0.224 | Caspase 3 stimulant | 0.224 0.138 DBMET01235 0.194 0.178 DBMET01236 | DBMET01235 | |
| 0.033 | 0.271 | 0.082 | ATPase (Vacuolar H+) inhibitor | 0.082 0.073 DBMET01235 | DBMET01235 | |
| 0.049 | 0.295 | 0.151 | Toll-Like receptor 3 antagonist | 0.151 0.014 DBMET00131 0.087 0.076 DBMET01234 0.117 0.032 DBMET01235 | DBMET00131 | |
| 0.048 | 0.303 | 0.112 | Glutamate (mGluR7) agonist | 0.112 0.039 DBMET00131 | DBMET00131 | |
| 0.025 | 0.284 | 0.091 | Adrenaline agonist | 0.091 0.044 DBMET01236 | DBMET01236 | |
| 0.057 | 0.319 | 0.137 | Neuropeptide Y1 antagonist | 0.137 0.086 DBMET00132 | DBMET00132 | |
| 0.03 | 0.306 | 0.082 | Glycine receptor agonist | 0.082 0.036 DBMET01234 | DBMET01234 | |
| 0.044 | 0.325 | 0.164 | Angiogenesis stimulant | 0.164 0.114 DBMET01234 | DBMET01234 | |
| 0.049 | 0.339 | 0.111 | Interleukin 4 antagonist | 0.111 0.099 DBMET01236 | DBMET01236 | |
| 0.076 | 0.369 | 0.208 | 12-Lipoxygenase inhibitor | 0.208 0.142 DBMET01236 | DBMET01236 | |
| 0.049 | 0.345 | 0.167 | Interleukin antagonist | 0.167 0.106 DBMET01234 | DBMET01234 | |
| 0.027 | 0.348 | 0.113 | GABA C receptor antagonist | 0.113 0.06 DBMET01234 | DBMET01234 | |
| 0.031 | 0.353 | 0.136 | Thrombolytic | 0.136 0.093 DBMET01234 | DBMET01234 | |
| 0.045 | 0.393 | 0.124 | Histone deacetylase SIRT1 inhibitor | 0.115 0.097 DBMET00131 0.124 0.087 DBMET01234 0.122 0.089 DBMET01235 | DBMET01234 | |
| 0.122 | 0.499 | 0.458 | Calcium channel L-type activator | 0.453 0.049 DBMET00131 0.458 0.047 DBMET01235 | DBMET01235 | |
| 0.045 | 0.427 | 0.194 | Interleukin agonist | 0.194 0.126 DBMET01234 | DBMET01234 | |
| 0.044 | 0.433 | 0.138 | Hemostatic | 0.138 0.084 DBMET01234 | DBMET01234 | |
| 0.021 | 0.442 | 0.105 | GABA C receptor agonist | 0.105 0.061 DBMET01234 | DBMET01234 | |
| 0.047 | 0.647 | 0.145 | Death-associated protein kinase 2 inhibitor | 0.145 0.119 DBMET01234 | DBMET01234 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |